These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Ecological patterns and processes of temporal turnover within lung infection microbiota. Gavillet H; Hatfield L; Jones A; Maitra A; Horsley A; Rivett D; van der Gast C Microbiome; 2024 Mar; 12(1):63. PubMed ID: 38523273 [TBL] [Abstract][Full Text] [Related]
24. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Sibley CD; Parkins MD; Rabin HR; Surette MG Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923 [TBL] [Abstract][Full Text] [Related]
25. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis. Tay GT; Reid DW; Bell SC Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593 [TBL] [Abstract][Full Text] [Related]
26. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
27. An Innovative Protocol for Metaproteomic Analyses of Microbial Pathogens in Cystic Fibrosis Sputum. Graf AC; Striesow J; Pané-Farré J; Sura T; Wurster M; Lalk M; Pieper DH; Becher D; Kahl BC; Riedel K Front Cell Infect Microbiol; 2021; 11():724569. PubMed ID: 34513734 [TBL] [Abstract][Full Text] [Related]
28. Meta-analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients. Shi X; Gao Z; Lin Q; Zhao L; Ma Q; Kang Y; Yu J Genomics Proteomics Bioinformatics; 2019 Dec; 17(6):590-602. PubMed ID: 32171662 [TBL] [Abstract][Full Text] [Related]
34. Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection. Ghuneim LJ; Raghuvanshi R; Neugebauer KA; Guzior DV; Christian MH; Schena B; Feiner JM; Castillo-Bahena A; Mielke J; McClelland M; Conrad D; Klapper I; Zhang T; Quinn RA ISME J; 2022 Sep; 16(9):2065-2075. PubMed ID: 35597889 [TBL] [Abstract][Full Text] [Related]
35. Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome. Vieira J; Gallagher T; Sui HY; Jesudasen S; Whiteson K; O'Toole GA; Hanselmann K; Lai PS J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424248 [TBL] [Abstract][Full Text] [Related]
36. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces. Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MP; Rashid MU; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJ; Crielaard W mBio; 2015 Nov; 6(6):e01693-15. PubMed ID: 26556275 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis. Sherrard LJ; Tunney MM; Elborn JS Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272 [TBL] [Abstract][Full Text] [Related]
38. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung. Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513 [TBL] [Abstract][Full Text] [Related]